share_log

新天药业(002873.SZ)：公司产品院端收入占比约67% OTC市场对收入贡献约33%

Xintian Pharmaceutical (002873.SZ): The company's products account for about 67% of the company's revenue, and the OTC market contributes about 33% to revenue

Gelonghui Finance ·  Jan 17 19:11

Gelonghui, January 18 | Xintian Pharmaceutical (002873.SZ) said during a survey receiving institutional investors that from now on, in terms of sales channels, the company's products account for about 67% of the revenue on the hospital side, and the OTC market's contribution to revenue is about 33%. According to the company's market development strategy plan, it is expected that through continuous growth over the next 3-5 years, the hospital side market and OTC channel side will gradually form a 1:1 revenue contribution pattern, leading product revenue composition will be more reasonable and stable, and the second and third tier varieties will form a stable market foundation.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment